Cohance Life

{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "298.75",
    "chg": -0.55,
    "chgp": "-0.18%",
    "dir": -1,
    "prev_price": "299.30",
    "mcapval": "11,496.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE03QK01018",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "5.65 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3902695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_mojoScore_3902695.png",
        "date": "2026-03-20 10:10:45",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Cohance Lifesciences Ltd Valuation Shifts Amidst Challenging Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-valuation-shifts-amidst-challenging-market-performance-3897962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_valuationdot_3897962.png",
        "date": "2026-03-18 08:01:13",
        "description": "Cohance Lifesciences Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade as of early 2026. Despite a modest day gain of 2.63%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now reflect a more tempered market enthusiasm compared to its historical highs and peer benchmarks within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Falls to 52-Week Low of Rs.267.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-falls-to-52-week-low-of-rs26785-3880281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_priceRelatedfactors_3880281.png",
        "date": "2026-03-09 13:51:15",
        "description": "Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.267.85 today, marking a significant decline amid broader market pressures and company-specific performance issues."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3878616",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_mojoScore_3878616.png",
        "date": "2026-03-09 10:10:56",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3878614",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_mojoScore_3878614.png",
        "date": "2026-03-08 10:10:38",
        "description": "Cohance Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Cohance Lifesciences Declines 9.39%: 5 Key Factors Behind the 52-Week Lows",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-declines-939-5-key-factors-behind-the-52-week-lows-3878153",
        "imagepath": "",
        "date": "2026-03-07 12:06:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> New 52-week low at Rs.298</p>\n                    <p><strong>4 Mar:</strong> Further 52-week low at Rs.296.5</p>\n                    <p><strong>5 Mar:</strong> Continued decline to Rs.289.35 with valuation upgrade</p>\n                    <p><strong>6 Mar:</strong> Week closes at fresh 52-week low Rs.281.25</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.303.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.279.75</div><div class=\"stat-change negative\">-9.39%</div><..."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.281.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-hits-52-week-low-at-rs28125-3875828",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_priceRelatedfactors_3875828.png",
        "date": "2026-03-06 10:32:48",
        "description": "Cohance Lifesciences Ltd’s stock touched a fresh 52-week low of Rs.281.25 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment."
      },
      {
        "title": "Cohance Lifesciences Ltd Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-falls-to-52-week-low-amid-continued-downtrend-3873439",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_priceRelatedfactors_3873439.png",
        "date": "2026-03-05 10:20:32",
        "description": "Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.289.35 today, marking a significant milestone in its ongoing price decline. The stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial and operational metrics."
      },
      {
        "title": "Cohance Lifesciences Ltd Valuation Shifts Signal Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-valuation-shifts-signal-price-attractiveness-amid-sector-challenges-3872574",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_valuationdot_3872574.png",
        "date": "2026-03-05 08:01:48",
        "description": "Cohance Lifesciences Ltd has witnessed a notable improvement in its valuation parameters, shifting from a fair to an attractive rating despite ongoing headwinds in its stock performance. This recalibration in price attractiveness comes amid a broader sectoral context where peers remain largely expensive or very expensive, highlighting a potential opportunity for discerning investors."
      }
    ],
    "total": 529,
    "sid": "1003386",
    "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "13-Mar-2026",
      "details": "Grant of Stock Options",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Mar-2026",
      "details": "Investors Meet",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "24-Feb-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jasti Property & Equity Holdings Pvt Ltd & Others",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Cohance Lifesciences Ltd is Rated Sell

2026-03-20 10:10:45

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Cohance Lifesciences Ltd Valuation Shifts Amidst Challenging Market Performance

2026-03-18 08:01:13

Cohance Lifesciences Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade as of early 2026. Despite a modest day gain of 2.63%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now reflect a more tempered market enthusiasm compared to its historical highs and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

Cohance Lifesciences Ltd Stock Falls to 52-Week Low of Rs.267.85

2026-03-09 13:51:15

Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.267.85 today, marking a significant decline amid broader market pressures and company-specific performance issues.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-03-09 10:10:56

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-03-08 10:10:38

Cohance Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Cohance Lifesciences Declines 9.39%: 5 Key Factors Behind the 52-Week Lows

2026-03-07 12:06:04

Key Events This Week

2 Mar: New 52-week low at Rs.298

4 Mar: Further 52-week low at Rs.296.5

5 Mar: Continued decline to Rs.289.35 with valuation upgrade

6 Mar: Week closes at fresh 52-week low Rs.281.25

Week Open

Rs.303.70

Week Close

Rs.279.75

-9.39%

<...

Read full news article

Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.281.25

2026-03-06 10:32:48

Cohance Lifesciences Ltd’s stock touched a fresh 52-week low of Rs.281.25 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment.

Read full news article

Cohance Lifesciences Ltd Falls to 52-Week Low Amid Continued Downtrend

2026-03-05 10:20:32

Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.289.35 today, marking a significant milestone in its ongoing price decline. The stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial and operational metrics.

Read full news article

Cohance Lifesciences Ltd Valuation Shifts Signal Price Attractiveness Amid Sector Challenges

2026-03-05 08:01:48

Cohance Lifesciences Ltd has witnessed a notable improvement in its valuation parameters, shifting from a fair to an attractive rating despite ongoing headwinds in its stock performance. This recalibration in price attractiveness comes amid a broader sectoral context where peers remain largely expensive or very expensive, highlighting a potential opportunity for discerning investors.

Read full news article

View All News